Daily Archives: September 23, 2021
[Preprint] Third dose of Sinopharm inactivated SARS-CoV-2 vaccine induces robust B and T cell responses.
23 Sep, 2021 | 10:18h | UTCCommentaries:
Sinopharm’s COVID booster reverses antibody decline, enhances cell-based responses – study – Reuters
Cochrane Special Collection | De-implementation of low-value health care: resource prioritization in the COVID-19 pandemic era.
23 Sep, 2021 | 10:13h | UTCEditorial: Making wise choices about low‐value health care in the COVID‐19 pandemic – Cochrane Library
Commentary: Choosing health care wisely when resources are scarce – Evidently Cochrane
Commentaries on Twitter
?Our new editorial @cochranecollab: Making wise choices about low‐value health care in the COVID‐19 pandemic?https://t.co/qABVg7emRi
Linked Special Collection on low-value care: https://t.co/fstV8P8OQS#FreeAccess pic.twitter.com/h9KZGUm2kp
— Juan Franco ?️? (@juan_francomd) September 22, 2021
Sadly, some medical interventions are in use despite evidence against them. With @Cochrane_SH, we have published a Special Collection of Cochrane reviews of Low Value Care interventions and described the issue in an Editorial. We cannot afford wasted HC. https://t.co/PXUhaMZud2
— Karsten Juhl Jørgensen (@KarstenJuhl) September 22, 2021
Randomized phase 1/2 trial: Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in children and adolescents aged 3–17 years.
23 Sep, 2021 | 10:16h | UTC
‘Not a zero-sum game’: Sharing vaccines is in countries’ best interests.
23 Sep, 2021 | 10:09h | UTC‘Not a zero-sum game’: Sharing vaccines is in countries’ best interests – YaleNews
Original article: National interest may require distributing COVID-19 vaccines to other countries – Scientific Reports
Commentary on Twitter
"when US has reached the threshold for domestic herd immunity, it would be optimal to donate doses to other countries, as this would allow for a sharp reduction in the inflow of infected individuals from abroad"
– Modeling by @SaadOmer3, @amynmalik & co https://t.co/NFfp39tde6— Ahmed Mushfiq Mobarak (@mushfiq_econ) September 16, 2021
Systematic review: Clinical characteristics of multisystem inflammatory syndrome in adults.
23 Sep, 2021 | 10:12h | UTC
Commentary on Twitter
Multisystem inflammatory syndrome has been reported in adults worldwide but may be hard to distinguish from acute biphasic #COVID19 and postacute sequelae of COVID-19. More research is needed to understand this emerging clinical entity. https://t.co/OnerzsZKVB
— JAMA Network Open (@JAMANetworkOpen) September 22, 2021
WHO releases new compendium of innovative health technologies for COVID-19 and other priority diseases.
23 Sep, 2021 | 10:03h | UTC
The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable.
23 Sep, 2021 | 10:08h | UTC
Commentary on Twitter
Flaws in ivermectin data suggest that COVID-19 meta-analyses need rethinking
Correspondence from Jack Lawrence @GidMK @K_Sheldrick and colleagues https://t.co/lUqXX9DQjO pic.twitter.com/Oh848X1VGv
— Nature Medicine (@NatureMedicine) September 22, 2021
AHA Scientific Statement: Sleep‐disordered breathing and cardiovascular disease in children and adolescents.
23 Sep, 2021 | 10:02h | UTCNews release: Obstructive sleep apnea is common in kids and may impact blood pressure, heart health – American Heart Association
ERS clinical practice guidelines on treatment of sarcoidosis.
23 Sep, 2021 | 10:00h | UTCERS clinical practice guidelines on treatment of sarcoidosis – European Respiratory Journal
New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution.
23 Sep, 2021 | 10:05h | UTCNews release: New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution – World Health Organization
Original Guideline: WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide
Executive Summary: WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide
Commentaries:
Millions of deaths could be avoided under new air quality guidelines, WHO says – CNN
WHO slashes guideline limits on air pollution from fossil fuels – The Guardian
Consensus paper: Clinical indications for image-guided interventional procedures in the musculoskeletal system—part V, knee.
23 Sep, 2021 | 09:59h | UTCSee other articles in the series: Consensus paper: Clinical indications for image-guided interventional procedures in the musculoskeletal system.
Consensus Document: Evaluation and management of cancer patients presenting with acute cardiovascular disease—Part 1: acute coronary syndromes and acute pericardial diseases.
23 Sep, 2021 | 10:01h | UTCRelated:
Brazilian Cardio-oncology Guideline – 2020
Commentary on Twitter
?Evaluation & Management of Cancer ?presenting w/ Acute Coronary Syndromes & Acute Pericardial diseases. Consensus?from #ACVC & the @escardio council of #CardioOncology#CardioEd #CardioTwitter #CardioOnc #EchoFirst pic.twitter.com/QSNOv7uFK7
— Diego Segura (@SeguraCardio) September 19, 2021
Expert Analysis | Colchicine in acute coronary syndrome: when to commence?
23 Sep, 2021 | 09:56h | UTCColchicine in Acute Coronary Syndrome: When to Commence? – American College of Cardiology
Related:
Review: Colchicine and the heart.
M-A: Colchicine administration for percutaneous coronary intervention
M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease
Meta-analysis: Colchicine reduces new cardiovascular events in patients with coronary artery disease
Expert analysis: Efficacy and safety of colchicine in patients with chronic stable coronary disease
#ESCCongress – Randomized trial: Colchicine not beneficial for patients with acute coronary syndrome
Research: Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome
Importance of distinguishing between asthma and chronic obstructive pulmonary disease in primary care.
23 Sep, 2021 | 09:57h | UTC
Vasopressor-Sparing Strategies in Patients with Shock: A Scoping-Review and an Evidence-Based Strategy Proposition.
23 Sep, 2021 | 09:51h | UTC
Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy.
23 Sep, 2021 | 09:52h | UTC
Commentaries on Twitter
Just published on the @JAHA_AHA: from the original 1994 ITF criteria to the Padua criteria for the diagnosis of arrhythmogenic cardiomyopathy. #arvd #arvc #cmr #cardiomyopathy #Cardiology@DCorradoCardio @Cipeciop1964 @albcipri6 https://t.co/zPA2g2hsNg
— Alessandro Zorzi (@AlessandroZor14) September 18, 2021
?Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy#CardioEd #CardioTwitter #ePeeps @JAHA_AHA pic.twitter.com/WKPruB99kQ
— Diego Segura (@SeguraCardio) September 18, 2021
Phenotypes and subphenotypes of delirium: a review of current categorizations and suggestions for progression.
23 Sep, 2021 | 09:54h | UTC